150 related articles for article (PubMed ID: 24660985)
41. Melanoma risk associated with MC1R gene variants in Latvia and the functional analysis of rare variants.
Ozola A; Azarjana K; Doniņa S; Proboka G; Mandrika I; Petrovska R; Cēma I; Heisele O; Eņģele L; Streinerte B; Pjanova D
Cancer Genet; 2013 Mar; 206(3):81-91. PubMed ID: 23522749
[TBL] [Abstract][Full Text] [Related]
42. Molecular characterization of melanoma cases in Denmark suspected of genetic predisposition.
Wadt KA; Aoude LG; Krogh L; Sunde L; Bojesen A; Grønskov K; Wartacz N; Ek J; Tolstrup-Andersen M; Klarskov-Andersen M; Borg Å; Heegaard S; Kiilgaard JF; Hansen TV; Klein K; Jönsson G; Drzewiecki KT; Dunø M; Hayward NK; Gerdes AM
PLoS One; 2015; 10(3):e0122662. PubMed ID: 25803691
[TBL] [Abstract][Full Text] [Related]
43. [Phenotypic and histologic characteristics of cutaneous melanoma in patients with melanocortin-1 receptor polymorphisms].
Avilés JA; Lázaro P; Fernández LP; Benítez J; Ibarrola-Villava M; Ribas G
Actas Dermosifiliogr; 2012; 103(1):44-50. PubMed ID: 21737053
[TBL] [Abstract][Full Text] [Related]
44. Phenotypic variation in familial melanoma: consequences for predictive DNA testing.
Bergman W; Gruis NA
Arch Dermatol; 2007 Apr; 143(4):525-6. PubMed ID: 17438187
[No Abstract] [Full Text] [Related]
45. Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma.
Pho L; Grossman D; Leachman SA
Curr Opin Oncol; 2006 Mar; 18(2):173-9. PubMed ID: 16462187
[TBL] [Abstract][Full Text] [Related]
46. CDKN2A mutations in melanoma families from Uruguay.
Larre Borges A; Cuéllar F; Puig-Butillé JA; Scarone M; Delgado L; Badenas C; Milà M; Malvehy J; Barquet V; Núñez J; Laporte M; Fernández G; Levrero P; Martínez-Asuaga M; Puig S
Br J Dermatol; 2009 Sep; 161(3):536-41. PubMed ID: 19523171
[TBL] [Abstract][Full Text] [Related]
47. Clinical histopathological features and CDKN2A/CDK4/MITF mutational status of patients with multiple primary melanomas from Bologna: Italy is a fascinating but complex mosaic.
Dika E; Patrizi A; Rossi C; Turchetti D; Miccoli S; Ferracin M; Veronesi G; Scarfì F; Lambertini M
Ital J Dermatol Venerol; 2021 Oct; 156(5):599-605. PubMed ID: 32221274
[TBL] [Abstract][Full Text] [Related]
48. Characterization of Potential Melanoma Predisposition Genes in High-Risk Brazilian Patients.
Soares de Sá BC; Moredo LF; Torrezan GT; Fidalgo F; de Araújo ÉSS; Formiga MN; Duprat JP; Carraro DM
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958811
[TBL] [Abstract][Full Text] [Related]
49. Contribution of genetic factors for melanoma susceptibility in sporadic US melanoma patients.
Council ML; Gardner JM; Helms C; Liu Y; Cornelius LA; Bowcock AM
Exp Dermatol; 2009 May; 18(5):485-7. PubMed ID: 19320745
[TBL] [Abstract][Full Text] [Related]
50. MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients.
Ghiorzo P; Bonelli L; Pastorino L; Bruno W; Barile M; Andreotti V; Nasti S; Battistuzzi L; Grosso M; Bianchi-Scarrà G; Queirolo P
Exp Dermatol; 2012 Sep; 21(9):718-20. PubMed ID: 22804906
[TBL] [Abstract][Full Text] [Related]
51. The MC1R r allele does not increase melanoma risk in MITF E318K carriers.
Wallingford CK; Demeshko A; Krishnakripa AK; Smit DJ; Duffy DL; Betz-Stablein B; Pflugfelder A; Jagirdar K; Holland E; Mann GJ; Primiero CA; Yanes T; Malvehy J; Badenas C; Carrera C; Aguilera P; Olsen CM; Ward SV; Haass NK; Sturm RA; Puig S; Whiteman DC; Law MH; Cust AE; Potrony M; Soyer HP; McInerney-Leo AM
Br J Dermatol; 2023 May; 188(6):770-776. PubMed ID: 36879448
[TBL] [Abstract][Full Text] [Related]
52. Phenotypic and histologic characteristics of cutaneous melanoma in patients with melanocortin-1 receptor polymorphisms.
Avilés JA; Lázaro P; Fernández LP; Benítez J; Ibarrola-Villava M; Ribas G
Actas Dermosifiliogr; 2012 Jan; 103(1):44-50. PubMed ID: 22464597
[TBL] [Abstract][Full Text] [Related]
53. [Molecular biology of familial cases of human melanoma].
Kit OI; Vodolazhsky DL; Timoshkina NN; Przhedetsky YV; Khokhlova OV
Vopr Onkol; 2015; 61(6):889-97. PubMed ID: 26995975
[TBL] [Abstract][Full Text] [Related]
54. MC1R gene variants and sporadic malignant melanoma susceptibility in the Canary Islands population.
Córdoba-Lanús E; Hernández-Jiménez JG; Medina-Coello C; Espinoza-Jiménez A; González A; Rodríguez-Pérez MD; Carretero-Hernández G; Almeida P; Suárez-Hernández J; Perera-Molinero A; Fernández-de-Misa R
Arch Dermatol Res; 2014 Jan; 306(1):51-8. PubMed ID: 24170137
[TBL] [Abstract][Full Text] [Related]
55. MC1R, ASIP, TYR, and TYRP1 gene variants in a population-based series of multiple primary melanomas.
Helsing P; Nymoen DA; Rootwelt H; Vårdal M; Akslen LA; Molven A; Andresen PA
Genes Chromosomes Cancer; 2012 Jul; 51(7):654-61. PubMed ID: 22447455
[TBL] [Abstract][Full Text] [Related]
56. Novel CDKN2A mutation detected in Spanish melanoma pedigree.
de Torre C; Martínez-Escribano J
Exp Dermatol; 2010 Aug; 19(8):e333-5. PubMed ID: 20653773
[TBL] [Abstract][Full Text] [Related]
57. Multiple primary melanomas versus single melanoma of the head and neck: a comparison of genetic, diagnostic, and therapeutic implications.
Pollio A; Tomasi A; Pellacani G; Ruini C; Mandel VD; Fortuna G; Seidenari S; Ponti G
Melanoma Res; 2014 Jun; 24(3):267-72. PubMed ID: 24638154
[TBL] [Abstract][Full Text] [Related]
58. Variation in Cutaneous Patterns of Melanomagenesis According to Germline CDKN2A/CDK4 Status in Melanoma-Prone Families.
Sargen MR; Pfeiffer RM; Yang XR; Tucker MA; Goldstein AM
J Invest Dermatol; 2020 Jan; 140(1):174-181.e3. PubMed ID: 31326397
[TBL] [Abstract][Full Text] [Related]
59. Melanocortin 1 receptor (MC1R) variants in high melanoma risk patients are associated with specific dermoscopic ABCD features.
Quint KD; van der Rhee JI; Gruis NA; Ter Huurne JA; Wolterbeek R; van der Stoep N; Bergman W; Kukutsch NA
Acta Derm Venereol; 2012 Nov; 92(6):587-92. PubMed ID: 22965007
[TBL] [Abstract][Full Text] [Related]
60. High prevalence of the G101W germline mutation in the CDKN2A (P16(ink4a)) gene in 62 Italian malignant melanoma families.
Mantelli M; Barile M; Ciotti P; Ghiorzo P; Lantieri F; Pastorino L; Catricalà C; Torre GD; Folco U; Grammatico P; Padovani L; Pasini B; Rovini D; Queirolo P; Rainero ML; Santi PL; Sertoli RM; Goldstein AM; Bianchi-Scarrà G; ;
Am J Med Genet; 2002 Jan; 107(3):214-21. PubMed ID: 11807902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]